Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$215,781
in 9 filings

Net +$49,784,202. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 41 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-10 Bulis Veronica Sanchez VP, Corporate Controller Sale −416 $15.93 $7K 14,383
2026-11-10 Lee Gary K. Chief Scientific Officer Sale −129 $15.93 $2K 16,091
2026-11-10 Hill Stephen J. Chief Operating Officer Sale −88 $15.93 $1K 16,728
2026-11-10 Seely Lynn President and CEO Sale −545 $15.93 $9K 63,354
2026-11-04 ARCH Venture Partners IX, LLC 10% owner Purchase +2,321,262 $10.77 $25.0M 3,747,790
2026-11-04 ARCH Venture Fund XIII, L.P. 10% owner Purchase +2,321,262 $10.77 $25.0M 3,747,790
2026-10-12 Aguirre Jarrad Mattieu Chief Medical Officer Sale −422 $8.63 $4K 19,857
2026-09-10 Aguirre Jarrad Mattieu Chief Medical Officer Grant or award · Option (right to buy) +47,500 47,500
2026-09-10 Shook David Chief Medical Officer Sale −500 $12.70 $6K 20,423
2026-08-21 Lee Gary K. Chief Scientific Officer Sale −1,457 $15.54 $23K 16,220
2026-08-21 Hill Stephen J. Chief Operating Officer Sale −989 $15.54 $15K 16,816
2026-08-21 Seely Lynn President and CEO Sale −9,589 $15.54 $149K 63,899
2026-08-10 Bulis Veronica Sanchez VP, Corporate Controller Sale −621 $14.34 $9K 14,799
2026-08-10 Lee Gary K. Chief Scientific Officer Sale −131 $14.34 $2K 17,677
2026-08-10 Hill Stephen J. Chief Operating Officer Sale −89 $14.34 $1K 17,805
2026-08-10 Seely Lynn President and CEO Sale −390 $14.34 $6K 73,488
2026-07-27 Innovative Cellular Therapeutics Holdings Ltd 10% owner Other disposition −44,000 2,774,980
2026-07-27 Innovative Cellular Therapeutics Holdings Ltd 10% owner Other disposition −38,500 2,818,980
2026-07-17 Innovative Cellular Therapeutics Holdings Ltd 10% owner Sale 10b5-1 −10 $13.70 $137 2,857,480
2026-07-16 Innovative Cellular Therapeutics Holdings Ltd 10% owner Sale 10b5-1 −10 $13.73 $137 2,857,490

Page 1 of 8 · 156 trades